Christianson Gary

CIK 00014188811 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001418881

Recent Transactions

32 trades

Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−41,667→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−68,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−41,667→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−11,300→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−15,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−164,500→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−25,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−16,667→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−51,200→ 0 total
Disposition from Tender
Cascadian Therapeutics, Inc.
Common Stock
2018-03-09−6,515→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2018-02-01+164,500→ 164,500 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2018-01-11$3.92/sh−923→ 6,515 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2018-01-11+2,825→ 7,438 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2018-01-11−2,825→ 8,475 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-09-18+15,000→ 15,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2017-09-18+68,000→ 68,000 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-01-11+11,300→ 11,300 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2017-01-11+51,200→ 51,200 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2016-05-17+250,000→ 250,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2015-09-24+250,000→ 250,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2014-12-16+100,000→ 100,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2013-12-12+150,000→ 150,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2012-12-12+50,000→ 50,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2011-12-01+50,000→ 50,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2010-12-01+50,000→ 50,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2010-12-01+50,000→ 50,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2009-12-03+100,000→ 100,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2009-03-11+30,000→ 30,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2009-03-11+30,000→ 30,000 total

Companies

Cascadian Therapeutics, Inc.
Chief Operating Officer

Recent Filings

Address

2601 FOURTH AVENUE SUITE 500

SEATTLE, WA, 98121

View on SEC.gov